|
 |
About the conference:
Many drugs which are prescribed to children have not been adequately studied in the paediatric population. The lack of specific drugs is now a long-standing international problem. This has resulted in changes in legislation and updated regulatory guidance ensuring that medicines for use in children are of high quality, ethically researched and authorised appropriately. Pharmaceutical companies are now required to produce medicines specifically aimed at 0-17 year olds which has resulted in an increase in paediatric clinical trials.
SMi’s 6th annual conference on Paediatric Clinical Trials explores a range of key issues relating to the involvement of children in pharmaceutical development. There will be a strong focus on operational considerations when designing studies and an update on international regulations governing their conduct. There will also be a focus on ethical issues surrounding the increase in outsourcing clinical investigations to developing countries. Attendees will have access to presentations from a variety of senior professionals working in industry and renowned academic experts.
|
Our expert speaker line-up includes:
Klaus Rose, Paediatric Drug Development Consultant, Klausrose Consulting
Jane Lamprill, Paediatric Research Advisor & Trainer, Paediatric Research Consultancy
Philippe Auby, Director, International Clinical Research, Paediatric Neuropsychiatry, Lundbeck
Lisa Moore-Ramdin, Senior Medical Advisor, Paediatric Vaccines, GlaxoSmithKline
Sabine Desset-Brethes, Project Leader, Pharmaceutical & Analytical Development, Novartis
Georg Schmitt, Head of Toxicology & NCS Paediatrics, F. Hoffman-La Roche
David McIntosh, Global Scientific Affairs Senior Expert, Novartis
Stephen Heaton, Head of Safety Risk Management Planning & Coordination, Bayer Healthcare
Thomas Hassall, Senior Director, Regulatory Policy & Intelligence, Abbott Laboratories
Michael Bolger, Chief Scientist, Simulations Plus, Inc.
Philippa Smit-Marshall, Vice President and General Manager Paediatrics and Medical Sciences, PharmaNet
Steve Pinder, Managing Director, Envestia
Thorsten Ruppert, Senior Manager, Research Development Innovation, VFA
Joseph Standing, Paediatric Clinical Lecturer, School of Pharmacy, University College London
Dirk Matthys, Head of Paediatrics, Ghent University Hospital
Hans Stoetter, Head of the Paediatric Working Group, Swissmedic
Michael Beresford, Professor in Child Health, University of Liverpool
Why should you attend this event?
|
The design of paediatric clinical trials must be customized for children which brings about many regulatory, ethical and scientific challenges. Through explanatory presentations and panel discussion, delegates will leave the conference with a knowledge that will allow them to conduct safe and ethical studies with patients from this vulnerable population.
How will you benefit?
• Hear about the current issuessurrounding paediatric clinical research
• Discuss the practical considerations associated with drug discovery in the juvenile population
• Explore the ways to optimise benefit and minimise risks when conducting paediatric trials
• Learn from a range of case studies demonstrating real life experiences
• Network with key opinion leaders and industry associates to share knowledge
|
 |
| Sponsored by |
 |
Who should attend?
|
Heads of Department, Directors, Managers, Team Leaders Researchers and Scientists from:
• Research & Development
• Clinical Research
• Pharmacology
• Toxicology
• Formulation Development
• Clinical Trial Design
• Safety & Risk Management
• Regulatory Affairs
• Medical Writing
• Paediatrics
|
Previous attendees and participants have come from organisations including:
|
Accovion
Astellas
AstraZeneca
Bayer Schering
BioMS Medical
Boehringer Ingelheim
Celgene
Covance
Debiopharm SA
Eli Lilly
Fulcrum Pharma
GE Healthcare
|
GlaxoSmithKline
Grunenthal
ICON Development Solutions
Johnson & Johnson
Laboratorious Almirall
LEO Pharmaceuticals
Lundbeck
Merck Serono
Norgine Ltd.
Novartis
Novo Nordisk
Nycomed
Omnicom Healthcare |
Only For Children Pharmaceuticals
Orion Clinical Services
Paraxel
Pharmanet
Protopharma
QRxPharma, Inc.
SCM Pharma
Shire Allergan
Swedish Orphan Biovitrum
Vitalea
Voisin Consulting
Xceleron |
Venue details
In a corner of fashionable Kensington you will find the Copthorne Tara. Within easy reach of the shops and restaurants of Kensington High Street, Knightsbridge, and Notting Hill. The hotel is also close to the beautiful tree lined lanes and avenues of Kensington Gardens and Hyde Park, the Royal Albert Hall, the theatres of the west end and the world famous museums on the Cromwell Road
From Heathrow Airport: 30 mins by car; Heathrow Airport to Paddington Station 20 mins by Heathrow Express
Gatwick Airport to Victoria Station 30 mins by Gatwick Express Train;
Stansted Airport to Liverpool Station 50 mins by Stansted Express Train;
Luton Airport to Victoria Station 90 mins by coach.
Book your London hotel through SMi by simply faxing us a booking form! By booking through SMi Reservations we can offer discounted rates with fantastic savings at fabulous hotels.
For more information please visit our web site www.smi-online.co.uk/travel/hotels_london.asp
|